Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$386,222
+$305,568 QoQ
Shares Held
73,010
+239.5% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Derivatives in ACRS
reported options exposure · as of Mar 31, 2023CallValue
$809,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. ACRS ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ACRS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $386,222 | 73,010 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $80,654 | 21,508 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $431,676 | 143,414 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $234,507 | 123,425 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $221,998 | 156,337 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $182,071 | 119,001 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $37,698 | 15,201 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $23,451 | 20,393 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $44,269 | 40,245 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $84,649 | 68,266 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $184,714 | 175,919 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,603,926 | 234,150 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $885,483 | 85,389 | Shares | Sole | 2023-09-20 | |
| 2023-03-31 | $809,000 | 100,000 | Call | Sole | 2023-05-04 | |
| 2023-03-31 | $717,500 | 88,690 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $674,257 | 42,810 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $262,967 | 16,707 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $306,686 | 21,969 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,038,813 | 60,256 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,461,531 | 100,518 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $903,042 | 50,169 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $206,627 | 11,767 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $453 | 18 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $116 | 18 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $46 | 18 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $13,436 | 8,294 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $10,936 | 10,516 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||